HOME >> MEDICINE >> NEWS
Researchers probe enzyme that may lead to new SARS drugs

Researchers at the University of Illinois at Chicago and two other institutions have unraveled the structure of an important new drug target from the virus that causes SARS, severe acute respiratory syndrome.

"By unlocking the three-dimensional structure of this enzyme -- known as papain-like-protease (PLpro) -- we now have a molecular road map to design new drugs that could potentially treat SARS-infected patients, or perhaps patients suffering from other SARS-related illnesses such as the common cold, bronchitis or pneumonia," said Andrew Mesecar, associate professor of pharmaceutical biotechnology in the UIC College of Pharmacy. "We are attempting to use the same approach that has been accomplished in designing effective drugs against HIV protease, which has led to the development of new drugs to fight the AIDS virus."

The research is published in the March 27 issue of the Proceedings of the National Academy of Sciences.

Mesecar said that the knowledge gained from this new atomic structure -- the first-ever reported on this class of proteases -- has the potential to go beyond the treatment of patients infected with the coronavirus that causes SARS.

Coronaviruses, which produce upper respiratory tract infections, were discovered in the late 1960s. The viruses are responsible for 10 percent to 30 percent of all common colds. Recently, two new coronaviruses -- NL63 and HKU1 -- were found to cause many cases of severe pneumonia in children and the elderly throughout the world, he said.

"NL63 and HKU1 infections are severe and often lead to hospitalization," Mesecar said. "It is believed these viruses have been around a long time, but only recently have we developed the technology to identify and detect them. The SARS outbreak and quick response of the scientific community has led to the rapid development of such technology."

SARS was first reported in Asia in early 2003. Over the next several months the illness sp
'"/>

Contact: Sam Hostettler
samhos@uic.edu
312-355-2522
University of Illinois at Chicago
4-Apr-2006


Page: 1 2

Related medicine news :

1. Researchers suggest TB screening for all international adoptees
2. Researchers find vitamin B1 deficiency key to vascular problems for diabetic patients
3. Researchers link metal ions to neurodegenerative disease
4. Researchers develop criteria to detect bone mass deficiencies in children with chronic diseases
5. Researchers call for investigation into links between khat use and psychiatric disorders
6. Researchers use MRI to predict recovery after spinal cord injury
7. Researchers find deadly prescription drug effects 6 years before FDA
8. Researchers investigate impact of lifestyle on GI health
9. Researchers begin randomized double-blind trial of airway bypass treatment for emphysema
10. Researchers discover how antibiotic inhibits bacterial growth
11. Researchers urge caution in using ESAs for cancer-related anemia

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Researchers probe enzyme that may lead new SARS drugs

(Date:7/23/2014)... 23, 2014 “I believe that 70% of ... longtime spokesperson for Bragg Live Foods, whose products are sold ... opinion on the Sharon Kleyne Hour Power of Water radio ... the toxicity to big business farming, consumer demand and a ... Bragg Live Foods and daughter-in-law of Paul Bragg, who founded ...
(Date:7/23/2014)... Washington, DC’s long awaited Silver Line Metrorail will ... This expansion to the city’s current lines could translate ... area, located just outside the city. Not only will ... growth, but it will also expand the hotel options ... surrounding areas. , “We couldn’t be happier to have ...
(Date:7/23/2014)... On July 19 and 20, the HearStrong ... New York and New York Giants Health & Fitness Expo ... , The team, which included several hearing healthcare providers affiliated ... health screenings and answered any questions that attendees had about ... , Also sponsored by the NFL Players Association, HearStrong was ...
(Date:7/23/2014)... Il (PRWEB) July 23, 2014 ISI ... solutions, has released Infortel Speech Analytics, a ... solutions. , Infortel Speech Analytics gives users the ability ... and/or video recordings , as well as chat ... this solution may not be new, adding speech analytics ...
(Date:7/23/2014)... 23, 2014 Temecula Valley Southern ... Valley Southern California Wine Country artisan food and ... two nights genuinely nourishing. Savor like locals at ... and Vindemia wineries; EAT Marketplace, Palumbo’s Ristorante, Robin’s ... Olive Oil,” announced Kimberly Adams, president and CEO, ...
Breaking Medicine News(10 mins):Health News:U.S. Farms Toxic Says Health Food Pioneer on Sharon Kleyne Hour Power of Water 2Health News:Washington, DC’s Metrorail Expansion Opening this Week Changes the Capital City’s Landscape for Locals and Visitors Alike 2Health News:Washington, DC’s Metrorail Expansion Opening this Week Changes the Capital City’s Landscape for Locals and Visitors Alike 3Health News:Washington, DC’s Metrorail Expansion Opening this Week Changes the Capital City’s Landscape for Locals and Visitors Alike 4Health News:The HearStrong Foundation Provides Hearing Healthcare Awareness at the NBC 4 New York and New York Giants Health & Fitness Expo 2014 2Health News:ISI Telemanagement Solutions, Inc. Releases Infortel® Speech Analytics 2Health News:ISI Telemanagement Solutions, Inc. Releases Infortel® Speech Analytics 3Health News:12 Artisan Food and Wine Experiences in Temecula Valley Southern California Wine County 2Health News:12 Artisan Food and Wine Experiences in Temecula Valley Southern California Wine County 3Health News:12 Artisan Food and Wine Experiences in Temecula Valley Southern California Wine County 4
(Date:7/22/2014)... 2014 BiologicTx ® today announced their ... Kidney Paired Donation transplant exchange utilizing BiologicTx,s proprietary matching ... 9 at the Miami Transplant Institute, located at Jackson ... Kidney Paired Donation (KPD) is an ... kidney transplant with one another due to incompatible blood ...
(Date:7/22/2014)... 22, 2014  PuraMed BioScience®, Inc., (OTCBB: PMBS), ... medicinal and healthcare products, announced today that the ... Aid. "We are pleased to sponsor ... CEO and Chairman of PuraMed BioScience. "Research shows ... zones experience migraines much more frequently than the ...
(Date:7/22/2014)...  Neurotrope Bioscience, Inc., a subsidiary of Neurotrope, Inc. ... with the Icahn School of Medicine at ... ) to utilize its proprietary information and data package ... Niemann-Pick Type C Disease (NPC), a rare disease, mostly ... license also covers other diseases and disorders relying on ...
Breaking Medicine Technology:BiologicTx Paired Donation Aids In Successful Kidney Transplants 2BiologicTx Paired Donation Aids In Successful Kidney Transplants 3PuraMed BioScience Partners with Operation Troop Aid to Sponsor Care Packages 2PuraMed BioScience Partners with Operation Troop Aid to Sponsor Care Packages 3Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 2Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 3Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 4Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 5
Cached News: